GENE ONLINE|News &
Opinion
Blog

Cancer Immunotherapy
F-star Announces Collaboration with Takeda to Develop Next Generation Immunotherapeutics
2023-07-09
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Combining STING Agonists and pHLIPs to Enhance Cancer Treatments
2022-11-09
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
Vaccines Against Cancers May Be the Future
2022-05-30
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Pheast Gets a $76 Million Series A to Feed Pipeline of Immune Checkpoint Inhibitors
2022-04-27
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
1 2
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top